Harvard Apparatus Regenerative Technology

Performance

About Harvard Apparatus Regenerative Technology

Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on regenerative medicine using a patient’s own stem cells grown on hollow tubular scaffolds to regenerate damaged organ tissue. The company develops esophageal and bronchial implant technologies, including the Cellspan Esophageal Implant, and operates globally with headquarters in the United States and a presence in Hong Kong. It researches treating conditions such as esophageal atresia and other congenital or acquired tissue defects, advancing clinical trials and seeking regulatory approvals. The organization positions itself as advancing regenerative solutions for complex organ systems using patient-derived cells and scaffold-based engineering.